SEC 13F Intelligence

Amova Asset Management Americas, Inc. / NTLA

Amova Asset Management Americas, Inc.’s Intellia Therapeutics Inc Position

Does Amova Asset Management Americas, Inc. own Intellia Therapeutics Inc (NTLA)? Yes — 1.97M shares worth $25M (+0.36% of its 13F portfolio) as of Q1 2026, down from 2.19M shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
1.97M
% of Portfolio
+0.36%
Quarters Held
30
currently held

Position History NTLA

Reported value by quarter
Q4 ’18: $82,000Q4 ’18Q1 ’19: $18MQ2 ’19: $84MQ3 ’19: $97MQ4 ’19: $105MQ4 ’19Q1 ’20: $173MQ2 ’20: $124MQ3 ’20: $122MQ4 ’20: $278MQ4 ’20Q1 ’21: $389MQ2 ’21: $507MQ3 ’21: $322MQ4 ’21: $328MQ4 ’21Q1 ’22: $192MQ2 ’22: $141MQ3 ’22: $164MQ4 ’22: $104MQ4 ’22Q1 ’23: $111MQ2 ’23: $138MQ3 ’23: $111MQ4 ’23: $106MQ4 ’23Q1 ’24: $93MQ2 ’24: $73MQ3 ’24: $65MQ4 ’24: $35MQ4 ’24Q1 ’25: $20MQ2 ’25: $25MQ3 ’25: $41MQ4 ’25: $20MQ4 ’25Q1 ’26: $25Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.97M$25M+0.36%
Q4 20252.19M$20M+0.23%
Q3 20252.35M$41M+0.39%
Q2 20252.67M$25M+0.25%
Q1 20252.83M$20M+0.26%
Q4 20242.99M$35M+0.38%
Q3 20243.15M$65M+0.73%
Q2 20243.26M$73M+0.84%
Q1 20243.40M$93M+0.93%
Q4 20233.48M$106M+1.02%
Q3 20233.52M$111M+1.33%
Q2 20233.39M$138M+1.46%
Q1 20233.11M$111M+1.28%
Q4 20222.98M$104M+1.49%
Q3 20222.96M$164M+2.10%
Q2 20222.78M$141M+1.74%
Q1 20222.87M$192M+1.41%
Q4 20212.75M$328M+1.72%
Q3 20212.40M$322M+1.38%
Q2 20213.06M$507M+1.99%
Q1 20214.84M$389M+1.90%
Q4 20205.10M$278M+1.58%
Q3 20206.06M$122M+1.08%
Q2 20206.18M$124M+1.62%
Q1 202014.18M$173M+1.63%
Q4 20197.18M$105M+1.66%
Q3 20197.24M$97M+1.72%
Q2 20195.16M$84M+1.66%
Q1 20191.07M$18M+0.48%
Q4 20186.0K$82,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amova Asset Management Americas, Inc.’s full portfolio or all institutional holders of NTLA.